Harrow Health Inc (HROW) Stock Analysis

Harrow Health Inc (HROW) is a publicly traded company in the HEALTHCARE sector. It trades at $32.86, carries a market capitalization of $1.27B. This page summarizes the public market data, fundamentals, and frequently asked questions for HROW, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

Market Sentiment

Harrow Health Inc currently has a Neutral sentiment score of 0.02.

About Harrow Health Inc

Harrow Health, Inc. is a leading healthcare company headquartered in San Diego, California, specializing in the development and commercialization of innovative ophthalmic products. With a strong focus on proprietary formulations and drug delivery technology, Harrow Health is dedicated to enhancing patient outcomes across a spectrum of ocular conditions and surgical requirements. The company boasts a robust portfolio of FDA-approved products, positioning it to effectively leverage the increasi...

GNG Research Analysis

GNG Research scores Harrow Health Inc (HROW) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for HROW.

Frequently Asked Questions

Does HROW pay dividends?

Harrow Health Inc (HROW) does not currently pay a regular dividend.

What is HROW's market cap?

Harrow Health Inc (HROW) has a market capitalization of $1.27B with a current stock price of $32.86.